Dino

Demecolcine Un2811-II

Demecolcine Un2811-II

Synonyms N-Deacetyl-N-methylcolchicine; 6,7-Dihydro-1,2,3,10-tetramethoxy-7-(methylamino)benzo[a]heptalen-9(5H)-one; N-Methyl-N-desacetylcolchicine; Colchamine; Santavy's substance F

CAS Number: 477-30-5 Molecular Formula: C21H25NO5 Molecular Weight: 371.4

Beilstein Registry Number: 2822892 EC Number: 207-514-6 MDL Number: MFCD00075459

Configure Your Product:

SKU 02190195-CF
Price:
$45.80
In Stock
Request a quote
Description

Product Description

Demecolcine, also known as colcemid, is a drug used in chemotherapy. It is closely related to the natural alkaloid colchicine with the replacement of the acetyl group on the amino moiety with methyl, but it is less toxic.

Application Notes

Demecolcine is a antineoplastic agent used to immobilize chromosomes by inactivating the spindle fiber mechanism during metaphase. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.

Usage Statement

Research Use Only (RUO). Ready for CE IVD labeling of clinical applications.

Key Applications

Antineoplastic agent | Cancer research

Specifications
SKU 02190195-CF
Application Notes Demecolcine is a antineoplastic agent used to immobilize chromosomes by inactivating the spindle fiber mechanism during metaphase. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.
Beilstein Registry Number 2822892
Biochemical Physiological Actions Demecolcine depolymerizes microtubules; blocks mitosis at metaphase. Often in karyotyping and cell cycle research it is desirable to increase the yield of mitotic cells in a particular phase of the cell cycle. This can be achieved in a variety of ways with the most popular being the use of a cell cycle synchronizing agent such as demecolcine. Demecolcine will arrest cells in metaphase with no remarkable effect on the biochemical events in mitotic cells or in synchronized G1 and S phase cells. White blood cells are often treated with demecolcine to arrest cells in metaphase.
EC Number 207-514-6
Hazard Statements H300
Applications Antineoplastic agent | Cancer research
Melting Point 186 °C (Lit.)
Molecular Formula C21H25NO5
Molecular Weight 371.4
Personal Protective Equipment Eyeshields, Faceshields, Gloves, respirator cartridges
Physical Appearance Pale Yellow Powder
Purity >98%
RTECS Number GH0800000
Safety Symbol GHS06
Solubility Soluble in acidified water, alcohol, ether, chloroform (10 mg/mL - clear, faint yellow solution) and benzene.
Storage and Handling Store at +4 °C.
Typical Working Concentration Used in cell culture medium at a final concentration of 0.4 ug/mL.
Usage Statement Research Use Only (RUO). Ready for CE IVD labeling of clinical applications.